In conclusion, we have identified novel SHOX targets, many of which are consistent with known SHOX functions in limb development, and thereby provide novel insights into the genetic pathways leading to the clinical manifestation of SHOX deficiency. The gene discussed is SHOX; the disease is hyperinsulinemic hypoglycemia, familial, 4.